Available to SourceHuman Prescription DrugOncology & Specialty

Alyftrek (Vanzacaftor, Tezacaftor, and Deutivacaftor)

125 mg/1 / 50 mg/1 / 10 mg/1 · Film-Coated Tablet

By Vertex Pharmaceuticals Incorporated

Vanzacaftor, Tezacaftor, and Deutivacaftor · Tablet · 125 mg / 50 mg

NDC: 51167-121
Route: Oral
Therapeutic class: Breast Cancer Resistance Protein Inhibitors [MoA], Chloride Channel Activation Potentiators [MoA], Cystic Fibrosis Transmembrane Conductance Regulator Potentiator , Cytochrome P450 2C9 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
Marketing category: NDA

Request This Medication

*Expect a reply within 2 business hours with availability and pricing.

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request a quote

Request this medication.

Pick the package size you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.

DSCSA-compliant pedigree on every order
Cold-chain capable where applicable
Same-day fulfillment available for urgent needs

Related in Oncology & Specialty

See all →

Alyftrek (Vanzacaftor, Tezacaftor, and Deutivacaftor)

Additional information

Request this medication.

Related in Oncology & Specialty

Verzenio (Abemaciclib)

Verzenio (Abemaciclib)

Verzenio (Abemaciclib)

Verzenio (Abemaciclib)